Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1985-07-09
1989-06-06
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 23, 514283, 514345, 514729, 514738, 436 63, 436 64, A61K 3170, G01N 3348
Patent
active
048372374
ABSTRACT:
A method of regulating oncogene-mediated cell transformation in a mammalian host. Oncogenes having glycosylated expression products are regulated by administering an effective amount of a processing glucosidase inhibitor: a glucosidase I inhibitor, e.g., castanospermine, N-methyl-1-deoxynojirimycin, 1-deoxynojirimycin, 5-amino-5-deoxy-D-glucopyranose; or a glucosidase II inhibitor, e.g., bromoconduritol. The glucosidase I inhibitors are preferred, particularly castanospermine (CA) and N-methyl-1-deoxynojirimycin (MdN). Oncogenes having glycosylated expression products that are ultimately expressed on the plasma membrane or secreted from transformed cells are particularly susceptible to regulation by these anti-cancer drugs. Also provided is a method of regulating the immune system of a mammalian host. Administration of an effective amount of a processing glucosidase inhibitor suppresses proliferation and differentiation of monocytic and myeloblastic cells.
REFERENCES:
Pinter, A. et al., "Studies with Inhibitors of Oligosaccharide Processing Indicate a Functional Role for Complex Sugars in the Transport and Proteolysis of Friend Mink Cell Focus-Inducing Murine Leukemia Virus Envelope Proteins", Virology, vol. 136, pp. 196-210, 1984.
Pan, Y. T. et al., "Castanospermine Inhibits the Processing of the Oligosaccharide Portion of the Influenza Viral Hemagglutinin", Biochemistry, pp. 3975-3984, 1983.
Virology 132:95-109, 1984.
Molecular and Cellular Biology 4(10): 1999-2009, Oct. 1984.
Proc. Natl. Acad. Sci. U.S.A. 81: 85-89, Jan. 1984.
TIBS, pp. 32-33, Jan. 1984.
The EMBO Journal 4(1): 105-112, 1985.
Cell 40: 971-981, Apr. 1985.
Cell 39: 327-337, Dec. 1984 (Part 1).
Nichols Everett J.
Rohrschneider Larry R.
Fred Hutchinson Cancer Research Center
Hazel Blondel
Nichols Everett J.
LandOfFree
Therapy using glucosidase processing inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy using glucosidase processing inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy using glucosidase processing inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-40807